A Splice Variant, Not a Separate Gene
MGF (Mechano Growth Factor) is not a distinct gene product — it is the IGF-1Ec alternatively spliced variant of the IGF-1 gene, expressed preferentially by skeletal muscle in response to mechanical stress. Understanding MGF research requires understanding what distinguishes it from systemic IGF-1.
The research-grade peptide is available as MGF 2mg.
The Mechanical Loading Response
When skeletal muscle experiences mechanical loading, the IGF-1 gene undergoes alternative splicing that produces the IGF-1Ec (MGF) transcript. The protein product:
- Has a 24-amino-acid C-terminal E-peptide extension
- Acts locally at the site of production
- Has a short half-life (minutes in circulation)
- Produces biological effects distinct from mature IGF-1
The localized, short-acting nature is the defining research property.
Satellite Cell Activation
The primary MGF research target is the skeletal muscle satellite cell. MGF:
- Activates dormant satellite cells
- Promotes satellite cell proliferation
- Delays myogenic differentiation (keeping cells in the proliferative pool longer)
- Contributes to myofiber hypertrophy after injury or loading
The satellite cell pool is the regenerative reserve of skeletal muscle — research into its regulation is foundational to muscle biology.
Native MGF vs PEG-MGF
Two research peptides exist for MGF studies:
- Native MGF: Short half-life, site-specific research
- PEG-MGF: Polyethylene glycol-modified, extended systemic half-life
The choice depends on the research question:
| Research Goal | Compound |
|---|---|
| Local satellite cell response | Native MGF |
| Systemic IGF-1Ec signaling | PEG-MGF |
| Site-of-injection pharmacology | Native MGF |
| Sustained circulating levels | PEG-MGF |
Research Protocol Design
Native MGF's short half-life requires either:
- Frequent site-specific administration
- Acceptance that systemic effects are minimal
- Combined protocols with other GH-axis compounds
Combining native MGF with GH-releasing compounds (CJC/Ipamorelin) creates a research protocol that stimulates both systemic GH and local IGF-1Ec expression — a more complete GH-axis engagement.
Sourcing
See MGF 2mg for the standard research vial.